MEA Vascular Closure Devices Market

MEA Vascular Closure Devices Market Size (2022 to 2027)

The size of the Middle East and Africa Vascular Closure Devices Market was worth USD 0.66 billion in 2022 and is estimated to be growing at a CAGR of 5.5%, to reach USD 0.87 billion by 2027.

Vascular closure devices are the devices that are used to stop the blood flow from the puncture made on the femoral artery after certain diagnostic procedures. For example, large incisions are required for cardiovascular surgeries to replace valves in the heart.

Manual compression is not a good option during these surgeries. Vascular closure devices increase comfort and reduce discharge time for patients, and they can be used with ease. They reduce a lot of time and effort for physicians, and further supervision is not required. Technological advancements resulted in novel materials that degrade after a short period of time.

Increasing awareness of minimally invasive surgeries, a rising number of angiography procedures, the large geriatric population who require valve replacements are the major factors driving the market. In addition, technological advancements and the ease with which VCDs can be used are also propelling the market.

However, certain risks involving VCDs, such as groin infections and other disadvantages, and rising costs of devices, are restraining the market.

This research report on the MEA vascular closure devices market has been segmented and sub-segmented into the following categories:

By Type: 

• Passive Approximators
• Active Approximators
• External Haemostatic Devices

By Access: 

• Femoral
• Radial Access

By Procedure: 

• Interventional Cardiology
• Radiology/Vascular Surgery

By End User: 

• Acute Care Facilities
• Hospitals
• Clinics

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Regionally, the rising prevalence of cancer and the increasing focus of major players to expand in this region are expected to drive the market in this region.

KEY MARKET PLAYERS:

Biotronik GMBH & CO.KG, Abbott Vascular, Cardinal Health, Merit Medical Systems, Inc., Medtronic, Cardival Medical, Inc., Boston Scientific Corporation, Essential Medical, Inc., W L. Gore & Associates; St. Jude Medical, TZ Medical, Inc., and Scion BioMedical are prominent companies operating in the MEA vascular closure devices market.